New Drug Targets Tau in Alzheimer's | Dover News

Dover News Today | 2 Min News | The Daily News Now! · Jul 14, 2026 · 1m

A breakthrough in Alzheimer’s research is heating up as scientists unveil diranersen, an experimental drug that slashes tau protein production — a key driver of the disease — rather than targeting amyloid. Early results hint at slowing progression, sparking hope for a new era of treatments. While still in early stages, diranersen could reignite investment in tau-focused therapies, alongside other bold approaches like anti-tau vaccines and cholesterol-lowering drugs. Researchers are also tackling delivery hurdles to get treatments past the brain’s protective barrier — all in a race to outpace…